Wed, Nov 27, 2024
Glenmark Pharmaceuticals Inc, USA on Wednesday said it has launched Travoprost ophthalmic solution used in the treatment of glaucoma.
More >
Wed, Dec 27, 2023
Born in 1975, Lee starred as a rich family's father in "Parasite", and also played leading roles in South Korean movies including the 2012 thriller "Helpless" and 2014's "All About My Wife", among others.
Tue, Jun 06, 2023
The network, which operated in the darknet and used cryptocurrencies for payments, was spread across Poland, the Netherlands, the US and various states in India, an official said.
Tue, Mar 14, 2023
According to the drug regulator, the sale, stocking, exhibition, offer for sale or distribution of drugs through online means without a license could affect the quality of the drugs and pose danger to public health through self-medication or indiscriminate use of drugs.
Fri, Aug 19, 2022
Breast cancer is one of the most diagnosed cancer worldwide with an estimated 23 lakh patients diagnosed per year.
Thu, Jun 16, 2022
Asthma affects more than 34 million people in India, causing thousands of deaths every year.
Fri, Jan 21, 2022
Drug firm Laurus Labs on Friday said it has inked a pact with Geneva-based MPP (Medicine Patient Pool) for manufacturing the oral COVID-19 antiviral medication molnupiravir.
Tue, Jun 18, 2019
Seeking new treatments to slow the progression of Alzheimer's disease, researchers found the blood pressure drug nilvadipine increased blood flow to the brain's memory without affecting other parts of the brain. Alzheimer's disease is the most common form of dementia. The risk for the disease increases with age and the causes are largely unknown. Previous research has shown that blood flow to the brain declines in early Alzheimer's disease. These findings indicate that cerebral blood flow in patients with Alzheimer's can be reversed in some regions, according to the study published in the Journal of Hypertension. Nilvadipine is a calcium channel blocker used to treat high blood pressure. Researchers sought to discover whether nilvadipine could help treat Alzheimer's disease by comparing the use of nilvadipine and a placebo (a medicine or procedure prescribed for the psychological benefit) among people with mild to moderate Alzheimer's disease. Researchers note that sample sizes were too small and follow-up time too short to reliably study the effects of this cerebral blood flow increase on structural brain measures and cognitive measures. Previous studies have hinted that high blood pressure treatment could reduce the risk of developing dementia. The authors think that beneficial effects on brain blood flow could explain part of this effect.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
